November 05, 2014
Bernstein Liebhard LLP is investigating whether the Board of Directors of Covance Inc. (“Covance” or the “Company”) (NYSE: CVD) breached its fiduciary duty to its shareholders in agreeing to sell Covance to Laboratory Corporation of America Holdings (“LabCorp”).
Under the terms of the agreement, Covance shareholders will receive $75.76 in cash and 0.2686 LabCorp for each share they own. The investigation is focused on the potential unfairness of the price to Covance shareholders and the process by which the Covance Board of Directors considered and approved the transaction.
If you are interested in discussing your rights as a Covance stockholder, with no obligation or cost to you, please contact U. Seth Ottensoser at (877) 779-1414 or Ottensoser@bernlieb.com.
Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last twelve years.